TuHURA BIOSCIENCES, INC./NV Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
TuHURA BIOSCIENCES, INC./NV (HURA) had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $21.06 million as of 2014-12-31, per its 10-Q filed 2015-02-12.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-02-12
- 2014-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $21.06M.
- 2014-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $19.99M.
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $18.66M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $19.06M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-12-31 | $21.06M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $19.99M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $18.66M 10-Q · filed 2015-02-12 | |
| 2014-03-31 | $19.06M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $15.86M 10-K · filed 2014-08-28 | |
| 2013-09-30 | $15.00M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $21.79M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $14.98M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $3.84M 10-K · filed 2014-08-28 | -$65.01K 10-Q · filed 2013-01-18 |
| 2012-09-30 | -$61.76K 10-Q/A · filed 2012-12-20 | |
| 2012-06-30 | -$57.60K 10-Q · filed 2013-01-18 | |
| 2011-06-30 | -$38.72K 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |